Drug Development for Rare Mitochondrial Disorders
Author:
- 1 April 2013
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 10 (2) , 286-306
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- CoQ10 deficiencies and MNGIE: Two treatable mitochondrial disordersBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Primary and secondary CoQ10 deficiencies in humansBioFactors, 2011
- Why are there no proven therapies for genetic mitochondrial diseases?Mitochondrion, 2011
- Neuroprotective strategies involving ROS in Alzheimer diseaseFree Radical Biology and Medicine, 2011
- Exercise Capacity and Idebenone Intervention in Children and Adolescents With Friedreich AtaxiaArchives of Physical Medicine and Rehabilitation, 2010
- Coenzyme Q and mitochondrial diseaseDevelopmental Disabilities Research Reviews, 2010
- Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?Molecular Neurobiology, 2010
- The Evolution of Transcranial Laser Therapy for Acute Ischemic Stroke, Including a Pooled Analysis of NEST-1 and NEST-2Current Cardiology Reports, 2010
- Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemiaProceedings of the National Academy of Sciences, 2009
- Antioxidant use in Friedreich ataxiaJournal of the Neurological Sciences, 2008